孚能科技(688567.SH):成為柳州五菱的鋰電池系統總成供應商
格隆匯6月28日丨孚能科技(688567.SH)公吿,公司於近日收到柳州五菱汽車工業有限公司(“柳州五菱”)的《採購意向書》。通知公司成為其鋰電池系統總成供應商,為其多個車型提供動力電池系統。根據柳州五菱銷售計劃,2022年6月公司開始向柳州五菱批量供貨,預計供應約20萬套動力電池系統。
此次公司和柳州五菱的合作能夠緩解公司客户集中度高的風險,豐富了公司客户結構,加強了公司抗風險能力。由於柳州五菱在新能源汽車行業具有一定的市場地位,公司與其合作有助於提高公司市場份額,增加營業收入,為業績增長帶來新動力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.